MyFinsight
Home
Blog
About
Net income
$75,029K
(-4.73%↓ Y/Y)
Depreciation, amortization
and accretion
$22,582K
(70.67%↑ Y/Y)
Proceeds from stock
option exercises
$6,856K
(180.41%↑ Y/Y)
Stock-based compensation
$20,007K
(-10.37%↓ Y/Y)
Unrealized (gain) loss on
investment in equity...
-$9,536K
(-165.44%↓ Y/Y)
Other current and
noncurrent assets
-$5,088K
(-365.55%↓ Y/Y)
Inventory
-$3,301K
(-158.03%↓ Y/Y)
Accounts receivable
-$3,276K
(-243.18%↓ Y/Y)
Accounts payable
$1,390K
(-68.29%↓ Y/Y)
Amortization of debt-related
costs
$1,115K
(0.00%↑ Y/Y)
Long-term income tax
payable and other...
$603K
(193.93%↑ Y/Y)
Inventory adjustments
$454K
(-80.38%↓ Y/Y)
Net cash provided by
operating activities
$92,203K
(5.85%↑ Y/Y)
Net cash used in
financing activities
$4,505K
(104.58%↑ Y/Y)
Canceled cashflow
$50,178K
Effect of exchange rate
changes on cash, cash...
$36K
(-95.65%↓ Y/Y)
Canceled cashflow
$2,351K
Net increase
(decrease) in cash, cash...
$94,721K
(138.99%↑ Y/Y)
Canceled cashflow
$2,023K
Change in fair value of
contingent liabilities
$31,397K
Deferred taxes
-$13,071K
(-88.67%↓ Y/Y)
Gain on conversion of
installment note
$2,525K
Accrued expenses and
other current and...
-$1,989K
(66.55%↑ Y/Y)
Other
$997K
(140.84%↑ Y/Y)
Gain on sale of
business, net of...
$199K
Payments for minimum
statutory tax withholding...
$2,102K
(164.40%↑ Y/Y)
Payments of long-term
debt and other...
$248K
(293.65%↑ Y/Y)
Proceeds from employee
stock purchase plan
-$1K
(-100.05%↓ Y/Y)
Acquisition, net of cash
acquired-Lantheus Biosciences Ltd
-$312K
Net cash provided by
(used in) investing...
-$2,023K
(99.13%↑ Y/Y)
Canceled cashflow
$312K
Capital expenditures
$2,335K
(-70.67%↓ Y/Y)
Back
Back
Cash Flow
logo-lantheus-tm-svg
Lantheus Holdings, Inc. (LNTH)
logo-lantheus-tm-svg
Lantheus Holdings, Inc. (LNTH)
source: myfinsight.com